• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Susan Chi, MD


  • Bandopadhayay P, Bergthold G, London WB, Goumnerova LC, Morales La Madrid A, Marcus KJ, Guo D, Ullrich NJ, Robison NJ, Chi SN, Beroukhim R, Kieran MW, Manley PE.Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: An analysis of the Surveillance Epidemiology and End Results (SEER) database.Pediatr Blood Cancer. 2014 Jan 30.
  • Robison NJ, Campigotto F, Chi SN, Manley PE, Turner CD, Zimmerman MA, Chordas CA, Werger AM, Allen JC, Goldman S, Rubin JB, Isakoff MS, Pan WJ, Khatib ZA, Comito MA, Bendel AE, Pietrantonio JB, Kondrat L, Hubbs SM, Neuberg DS, Kieran MW.A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer.Pediatr Blood Cancer. 2014 Apr;61(4):636-42.
  • Robison NJ, Prabhu SP, Sun P, Chi SN, Kieran MW, Manley PE, Cohen LE, Goumnerova L, Smith ER, Scott RM, London WB, Ullrich NJ.Predictors of neoplastic disease in children with isolated pituitary stalk thickening.Pediatr Blood Cancer. 2013 May 14.
  • Singh A, Lun X, Jayanthan A, Obaid H, Ruan Y, Strother D, Chi SN, Smith A, Forsyth P, Narendran A.Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): Favorable activity of targeting EGFR- ErbB2 signaling with lapatinib.Mol Oncol. 2013 Jan 11.
  • Kieran MW, Roberts CW, Chi SN, Ligon KL, Rich BE, Macconaill LE, Garraway LA, Biegel JA.Absence of oncogenic canonical pathway mutations in aggressive pediatric rhabdoid tumors.Pediatr Blood Cancer. 2012 Dec 15;59(7):1155-7.
  • Manley PE, McKendrick K, McGillicudy M, Chi SN, Kieran MW, Cohen LE, Kothare S, Michael Scott R, Goumnerova LC, Sun P, London W, Marcus KJ, Pomeroy SL, Ullrich NJ.Sleep dysfunction in long term survivors of craniopharyngioma.J. Neurooncol. 2012 Jul;108(3):543-9.
  • Broniscer A, Baker JN, Baker SJ, Chi SN, Geyer JR, Morris EB, Gajjar A.Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma.Cancer. 2010 Oct 1;116(19):4632-7.
  • Wong JM, Chi SN, Marcus KJ, Levine BS, Ullrich NJ, MacDonald S, Lechpammer M, Goumnerova LC.Germinoma with malignant transformation to nongerminomatous germ cell tumor.J Neurosurg Pediatrics. 2010 Sep;6(3):295-8.
  • Gururangan S, Chi SN, Young Poussaint T, Onar-Thomas A, Gilbertson RJ, Vajapeyam S, Friedman HS, Packer RJ, Rood BN, Boyett JM, Kun LE.Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study.J Clin Oncol. 2010 Jun 20;28(18):3069-75.
  • Zacharoulis S, Chi S, Kadota R, Kieran M.Biological modification strategies following marrow ablative, high-dose chemotherapy (HDCT) with autologous hematopoietic stem cell rescue (AHSCR) for pediatric brain tumors.Pediatr Blood Cancer. 2010 Apr;54(4):654-6. Review.
  • Fangusaro J, Chi S.Introduction to a special issue on pediatric neuro-oncology.J Child Neurol. 2009 Nov;24(11):1341-2.
  • Turner CD,Chordas CA,Liptak CC,Rey-Casserly C,Delaney BL,Ullrich NJ,Goumnerova LC,Scott RM,Begley HC,Fletcher WJ,Yao X,Chi S,Kieran MW.Medical, psychological, cognitive and educational late-effects in pediatric low-grade glioma survivors treated with surgery only.Pediatr Blood Cancer. 2009 Sep;53(3):417-23.
  • Manley P,Li X,Turner C,Chi S,Zimmerman MA,Chordas C,Gordon A,Baker A,Ullrich NJ,Goumnerova L,Marcus K,Hoffman K,Kieran MW.A prospective, blinded analysis of A-PROTEIN (recoverin or CAR protein) levels in pediatric patients with central nervous system tumors.Pediatr Blood Cancer. 2009 Sep;53(3):343-7.
  • Chi SN,Zimmerman MA,Yao X,Cohen KJ,Burger P,Biegel JA,Rorke-Adams LB,Fisher MJ,Janss A,Mazewski C,Goldman S,Manley PE,Bowers DC,Bendel A,Rubin J,Turner CD,Marcus KJ,Goumnerova L,Ullrich NJ,Kieran MW.Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor.J Clin Oncol. 2009 Jan 20;27(3):385-9.
  • Snuderl M,Chi SN,De Santis SM,Stemmer-Rachamimov AO,Betensky RA,De Girolami U,Kieran MW.Prognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomas.J Neuropathol Exp Neurol. 2008 Sep;67(9):911-20.
  • Gilheeney SW, Saad A, Chi S, Turner C, Ullrich NJ, Goumnerova L, Scott RM, Marcus K, Lehman L, De Girolami U, Kieran MW.Outcome of pediatric pineoblastoma after surgery, radiation and chemotherapy.J Neurooncol. 2008 Aug;89(1):89-95.
  • Chi S,Cao H,Chen J,McNiven MA.Eps15 mediates vesicle trafficking from the trans-Golgi network via an interaction with the clathrin adaptor AP-1.Mol Biol Cell. 2008 Aug;19(8):3564-75.
  • Zacharoulis S, Levy A, Chi SN, Gardner S, Rosenblum M, Miller DC, Dunkel I, Diez B, Sposto R, Ji L, Asgharzadeh S, Hukin J, Belasco J, Dubowy R, Kellie S, Termuhlen A, Finlay J.Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue.Pediatr Blood Cancer. 2007 Jul;49(1):34-40.
  • Ullrich NJ, Robertson R, Kinnamon DD, Scott RM, Kieran MW, Turner CD, Chi SN, Goumnerova L, Proctor M, Tarbell NJ, Marcus KJ, Pomeroy SL.Moyamoya following cranial irradiation for primary brain tumors in children.Neurology. 2007 Mar 20;68(12):932-8.
  • Turner CD, Chi S, Marcus KJ, MacDonald T, Packer RJ, Poussaint TY, Vajapeyam S, Ullrich N, Goumnerova LC, Scott RM, Briody C, Chordas C, Zimmerman MA, Kieran MW.Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme.J Neurooncol. 2007 Mar;82(1):95-101.
  • Ullrich NJ, Marcus K, Pomeroy SL, Turner CD, Zimmerman M, Lehmann LE, Scott RM, Goumnerova L, Gillan E, Kieran MW, Chi SN.Transverse Myelitis After Therapy For Primitive Neuroectodermal Tumors.Pediatr Neurol. 2006 Aug;35(2):122-125.
  • Kieran MW, Turner CD, Rubin JB, Chi SN, Zimmerman MA, Chordas C, Klement G, Laforme A, Gordon A, Thomas A, Neuberg D, Browder T, Folkman J.A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer.J Pediatr Hematol Oncol. 2005 Nov;27(11):573-81.
  • Zimmerman MA, Goumnerova LC, Proctor M, Scott RM, Marcus K, Pomeroy SL, Turner CD, Chi SN, Chordas C, Kieran MW.Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor.J Neurooncol. 2005 Mar;72(1):77-84.
  • Chi SN, Gardner SL, Levy AS, Knopp EA, Miller DC, Wisoff JH, Weiner HL, Finlay JL.Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.J Clin Oncol. 2004 Dec 15;22(24):4881-7.